Interim Guidelines Describe Using High‐Risk Human Papillomavirus Testing as Alternative for Primary Cervical Cancer Screening

Publisher： John Wiley & Sons Inc

E-ISSN： 1542-2011|60|3|330-331

ISSN： 1526-9523

Source： JOURNAL OF MIDWIFERY & WOMEN'S HEALTH, Vol.60, Iss.3, 2015-05, pp. : 330-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 2, 2015-07 ,pp. : 420-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

The human papillomavirus Test of Cure: A lesson on compliance with the NHMRC guidelines on screening to prevent cervical cancer

By  

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 55, Iss. 2, 2015-04 ,pp. : 185-190

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Papillomavirus DNA Testing for Cervical Cancer Screening: Practical Aspects in Developing Countries

By Belinson Suzanne E.   Belinson Jerome L.  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 4, 2010-08 ,pp. : 215-222

Adis International

Access to resources Recommend Favorite

No high-risk human papillomavirus infection in prostate cancer tissues

By Smelov Vitaly   van Moorselaar Jeroen   Startsev Vladimir   Smelova Natalia   Grigorovich Edward   Meijer Chris   Morréé Servaas  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 5, 2011-05 ,pp. : 399-400

Informa Healthcare

Access to resources Recommend Favorite

Primary human papillomavirus testing

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 5, 2015-05 ,pp. : 269-270

John Wiley & Sons Inc

Access to resources Recommend Favorite